Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Features include always present findings: Global developmental delay; and very common findings: Constipation and Atypical behavior. 37 total HPO annotations.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Brain and nerves | 8 | Seizure, Aggressive behavior, Anxiety |
Ears | 2 | Hearing loss (hearing impairment), Inner ear hearing loss (sensorineural hearing impairment) |
Head and neck | 2 | Coarse facial features, Thin upper lip vermilion |
Digestive system | 2 | Constipation, Feeding difficulties |
Eyes | 1 | Strabismus |
Muscles | 1 | Generalized hypotonia |
WAC-related intellectual disability is typically characterized by variable degrees of developmental delay and/or intellectual disability. Behavioral abnormalities including anxiety, attention-deficit/hyperactivity disorder, and/or autism spectrum disorder are observed in the majority of older children and adults. Most affected infants have significant but nonspecific features at birth such as neonatal hypotonia and feeding problems. Some affected individuals come to medical attention because of respiratory or vision problems; constipation is common. Although facial features may be mildly dysmorphic, they may not be observed universally and/or are often not specific enough to allow diagnosis. To date, 18 individuals have been identified with a pathogenic variant in WAC [, , , ].
Source: GeneReviews — "WAC-Related Intellectual Disability"
WAC function has not been fully characterized.
DeSanto-Shinawi syndrome due to WAC point mutation is associated with mutations in the WAC gene on chromosome 10.
To date only loss-of-function WAC variants have been reported in individuals with WAC-related intellectual disability. The small number of reported individuals is not sufficient to draw conclusions about genotype-phenotype correlations. Variability in intellectual function has been observed in individuals with the same WAC variant:
In two unrelated individuals with the variant intellectual disability was mild in one and moderate in the other .
In two sibs with the same variant, intellectual functioning was borderline in one and normal in the other, who (despite a full-scale IQ score of 98) was reported to perform below average in some verbal and nonverbal skills (e.g., confrontation naming or spatial orientation) and to score low in evaluation of motor function .
Source: GeneReviews — "WAC-Related Intellectual Disability"
To date all individuals with WAC-related intellectual disability have the disorder as the result of a de novo pathogenic variant or germline mosaicism. Based on the published cases, the penetrance is complete (100%). Reliable estimates on the penetrance of the disorder are however difficult to establish given that most affected individuals have been identified through the discovery of a de novo and/or loss-of-function variant in WAC.
Source: GeneReviews — "WAC-Related Intellectual Disability"
No formal clinical diagnostic criteria exist for WAC-related intellectual disability.
WAC-related intellectual disability (ID) should be considered in individuals with SOME OR ALL of the following suggestive findings:
Source: GeneReviews — "WAC-Related Intellectual Disability"
Developmental delay, neonatal feeding difficulties, and hypotonia, the most frequent features in WAC-related intellectual disability, are relatively common and have an extensive differential diagnosis. The syndromes in show significant phenotypic overlap with WAC-related ID and have been considered in affected individuals before the diagnosis of WAC-related ID was established. Table 2. Disorders to Consider in the Differential Diagnosis of WAC-Related Intellectual Disability
Disorder | Gene/Genetic Mechanism | MOI | Clinical Features of the Differential Diagnosis Disorder |
|---|---|---|---|
Overlapping w/WAC-Related ID | Distinguishing from WAC-Related ID Prader-Willi syndrome1 | Abnormal parent-specific imprinting w/in the Prader-Willi critical region | See footnote 2. |
Obesity food-seeking behaviors typically not a feature of WAC-related ID Smith-Magenis syndrome3 | Deletion or mutation of RAI1 on chromosome 17p11.24 | Virtually all de novo | Neonatal hypotonia w/feeding difficulties, DD ID, some behavioral disturbances (incl abnormal sleep patterns)5 |
Genetic testing for WAC is available. Testing is considered confirmatory for diagnosis.
No approved treatments are currently available for DeSanto-Shinawi syndrome due to WAC point mutation. The disease remains an area of unmet medical need.
Evaluations and Referrals Following Initial Diagnosis To establish the extent of disease and needs in an individual diagnosed with WAC-related intellectual disability, the evaluations and referrals outlined in are recommended. Note: Some evaluations are age dependent and may not be relevant at the time of initial diagnosis (e.g., recommendation for traits suggestive of autism spectrum disorder [ASD] in an infant). Table 3. Recommended Evaluations and Referrals Following Initial Diagnosis of WAC-Related Intellectual Disability
System/Concern | Evaluation | Comment |
|---|---|---|
Growth | Assessment of growth parameters to identify those w/failure to thrive | — |
Ophthalmology | Ophthalmology eval | — |
ENT | Audiology eval when clinical history is suggestive of a hearing problem | If abnormal, refer to otolaryngologist. Gastroenterology/ |
Feeding | Baseline eval for presence of reflux /or constipation; assessment for feeding problems | If needed, refer to gastroenterologist /or feeding therapist for treatment. |
Respiratory | Respiratory assessment when clinical history indicates presence of recurrent infections /or asthma |
Source: GeneReviews — "WAC-Related Intellectual Disability"
Search ClinicalTrials.gov in the US and EU Clinical Trials Register in Europe for access to information on clinical studies for a wide range of diseases and conditions. Note: There may not be clinical trials for this disorder.
Source: GeneReviews — "WAC-Related Intellectual Disability"
1 trial found
The following are appropriate.
Table 5.
Recommended Surveillance for Individuals with WAC-Related Intellectual Disability
System/Concern | Evaluation1
Eyes | Ophthalmologic eval
| Audiologic eval
| Regular dietary eval in infancy to ensure optimal nutritional status
| Monitor those w/renal abnormalities as clinically indicated.
| Monitor those w/seizures as clinically indicated.
| Behavioral assessment for anxiety, attention, aggressive or self-injurious behavior
| Monitor developmental progress educational needs.
1. The frequency with which each evaluation or reassessment occurs should be tailored to the needs of the affected individual.
Source: GeneReviews — "WAC-Related Intellectual Disability"
Phenotype severity distribution: 1 always present feature, 2 very common features, 3 common features.
Estimated prevalence: <1 in 1,000,000 (VERY_RARE).
1 clinical trial registered. Interventions under study include other interventions. Research is primarily sponsored by academic and government institutions.
10 publications have been identified in PubMed for DeSanto-Shinawi syndrome due to WAC point mutation. Research spans Case Report / Case Series (60%), Basic Science / Preclinical (30%), and Epidemiology / Natural History (10%).
Research Type | Count | % of Total |
|---|---|---|
Patient case studies | 6 | 60% |
Laboratory research | 3 | 30% |
Disease patterns and progression | 1 | 10% |
Okamoto N (2026). [PMID: 41622991](https://pubmed.ncbi.nlm.nih.gov/41622991/). *Am J Med Genet A*. [Case Report / Case Series]
Cipri S (2026). [PMID: 41700448](https://pubmed.ncbi.nlm.nih.gov/41700448/). *Am J Med Genet A*. [Case Report / Case Series]
Boonpraman N (2026). [PMID: 42247028](https://pubmed.ncbi.nlm.nih.gov/42247028/). *Mol Neurobiol*. [Basic Science / Preclinical]
Petroni S (2025). [PMID: 39936367](https://pubmed.ncbi.nlm.nih.gov/39936367/). *Eur J Ophthalmol*. [Case Report / Case Series]
Lee KH (2025). [PMID: 38826421](https://pubmed.ncbi.nlm.nih.gov/38826421/). *bioRxiv*. [Basic Science / Preclinical]
van der Horst SC (2025). [PMID: 39915438](https://pubmed.ncbi.nlm.nih.gov/39915438/). *Nat Commun*. [Basic Science / Preclinical]
Dwivedi A (2025). [PMID: 40347397](https://pubmed.ncbi.nlm.nih.gov/40347397/). *Mol Cell Pediatr*. [Case Report / Case Series]
Levy M (2025). [PMID: 38735835](https://pubmed.ncbi.nlm.nih.gov/38735835/). *Prenat Diagn*. [Epidemiology / Natural History]
Chen CP (2024). [PMID: 39004484](https://pubmed.ncbi.nlm.nih.gov/39004484/). *Taiwan J Obstet Gynecol*. [Case Report / Case Series]
Rahbeeni Z (2024). [PMID: 39493154](https://pubmed.ncbi.nlm.nih.gov/39493154/). *Cureus*. [Case Report / Case Series]
Data assembled from 8 of 12 sources · Last updated Sep 20, 2026, 5:14 PM UTC
Patient Advocacy Groups (PAGs) provide support, resources, and community for patients and caregivers.
Online Mendelian Inheritance in Man
European rare disease database
Genetic and Rare Diseases Info Center
Common questions about DeSanto-Shinawi syndrome due to WAC point mutation
Pitt-Hopkins syndrome | Haploinsufficiency of TCF4 | Most de novo | DD, ID, sleep disturbances, seizures, constipation; Facial features incl deep-set eyes wide mouth w/prominent lower face; Abnormal breathing pattern (seen in 2 persons w/WAC-related ID)6 |
ID usually more severe Angelman syndrome5 | Disruption of maternally imprinted UBE3A | See footnote 7. | DD, ID, sleep disorders; Seizures variably present in both (rare in WAC-related ID) |
Usually nonverbal, w/more severe ID KANSL1-related intellectual disability syndrome(Koolen-deVries syndrome) | 500- to 650-kb heterozygous deletion at chromosome 17q21.31 incl KANSL1 or a heterozygous KANSL1 intragenic pathogenic variant8 | Almost all de novo | Neonatal/childhood hypotonia DD w/associated ID; Abnormal vision, epilepsy, renal anomalies variably seen in both disorders (rare in WAC-related ID; in ~50% w/KANSL1-related ID |
Source: GeneReviews — "WAC-Related Intellectual Disability"
Genitourinary | Renal ultrasound exam when clinical history is suggestive of a renal problem | If abnormal, refer to nephrologist. Psychiatric/ |
Behavioral | For persons age 12 mos: clinical screening for behavior problems incl sleep disturbances, ADHD, anxiety, /or traits suggestive of ASD | Consider referral for formal testing, incl Autism Diagnostic Interview Autism Diagnostic Observation Schedule. |
Neurologic | Assess for possible seizure activity. | If present, consider EEG /or referral to neurologist. Miscellaneous/ |
Other | Multidisciplinary developmental eval incl motor, speech/language eval, general cognitive, vocational skills | Referral to developmental pediatrician /or developmental psychologist Consultation w/clinical geneticist /or genetic counselor |